ESRT financial statements and SEC filings
ESRT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $768.27M | $135.65M | $43.40M | 10-K |
| 2024-12-31 | $767.92M | $158.71M | $47.44M | 10-K |
| 2023-12-31 | $739.57M | $146.71M | $49.04M | 10-K |
| 2022-12-31 | $727.04M | $127.03M | $36.44M | 10-K |
| 2021-12-31 | $624.09M | $79.13M | -$10.71M | 10-K/A |
| 2020-12-31 | $609.23M | $58.66M | -$16.71M | 10-K |
ESRT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $4.47B | $2.65B | $1.82B | 10-Q |
| 2024-12-31 | $4.51B | $2.73B | $1.78B | 10-K |
| 2023-12-31 | $4.22B | $2.49B | $1.73B | 10-K |
| 2022-12-31 | $4.16B | $2.48B | $1.68B | 10-K/A |
| 2021-12-31 | $4.28B | $2.60B | $1.68B | 10-K |
| 2020-12-31 | $4.15B | $2.42B | $1.73B | 10-K |
ESRT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $249.05M | -$198.50M | $38.17M | 10-K |
| 2024-12-31 | $260.89M | -$172.91M | $158.58M | 10-K |
| 2023-12-31 | $232.49M | -$139.33M | -$62.87M | 10-K |
| 2022-12-31 | $211.17M | -$126.27M | -$140.24M | 10-K |
| 2021-12-31 | $212.49M | -$95.04M | -$93.05M | 10-K/A |
| 2020-12-31 | $182.29M | -$143.12M | $257.17M | 10-K |